Search research articles
Contact Us
Filters
Showing results (251-260 of 427) with videos related to
Page
of 43
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load
Kai Neben, Anna Jauch, Thomas Hielscher, et al.
Cancer
|
April 12, 2013
Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients
Leopold Sellner, Christiane Heiss, Axel Benner, et al.
BMC Cancer
|
November 22, 2023
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials
Joseph Kauer, Emma P Freundt, Anita Schmitt, et al.
Leukemia
|
November 13, 2019
Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma
Maximilian Merz, Thomas Hielscher, David Schult, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2005
Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myeloma
M S Raab, F W Cremer, I N Breitkreutz, et al.
Blood Cancer Journal
|
October 14, 2024
Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma
Annika Werly, Mareike Hampel, Thomas Hielscher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 15, 2001
Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma
Y Liu, C D Sturgis, D M Grzybicki, et al.
Archives of Pathology & Laboratory Medicine
|
May 27, 2026
Interpretive Diagnostic Error Reduction: Guideline Update from the College of American Pathologists in Collaboration With the Association of Directors of Anatomic and Subspecialty Pathology
Suzanne M Dintzis, Juanita J Evans, Marisol Hernandez, et al.
Bone Marrow Transplantation
|
September 25, 2007
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)
M Hundemer, U Klein, D Hose, et al.
American Journal of Clinical Pathology
|
April 22, 2006
Double slide viewing as a cytology quality improvement initiative
Stephen S Raab, Chad H Stone, Chris S Jensen, et al.
Page
of 43
Search research articles
Search
Showing results (251-260 of 427) with videos related to
Sort By:
Page
of 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load
Kai Neben, Anna Jauch, Thomas Hielscher, et al.
Cancer
|
April 12, 2013
Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients
Leopold Sellner, Christiane Heiss, Axel Benner, et al.
BMC Cancer
|
November 22, 2023
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials
Joseph Kauer, Emma P Freundt, Anita Schmitt, et al.
Leukemia
|
November 13, 2019
Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma
Maximilian Merz, Thomas Hielscher, David Schult, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2005
Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myeloma
M S Raab, F W Cremer, I N Breitkreutz, et al.
Blood Cancer Journal
|
October 14, 2024
Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma
Annika Werly, Mareike Hampel, Thomas Hielscher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 15, 2001
Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma
Y Liu, C D Sturgis, D M Grzybicki, et al.
Archives of Pathology & Laboratory Medicine
|
May 27, 2026
Interpretive Diagnostic Error Reduction: Guideline Update from the College of American Pathologists in Collaboration With the Association of Directors of Anatomic and Subspecialty Pathology
Suzanne M Dintzis, Juanita J Evans, Marisol Hernandez, et al.
Bone Marrow Transplantation
|
September 25, 2007
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)
M Hundemer, U Klein, D Hose, et al.
American Journal of Clinical Pathology
|
April 22, 2006
Double slide viewing as a cytology quality improvement initiative
Stephen S Raab, Chad H Stone, Chris S Jensen, et al.
Page
of 43